Effect of Magnesium Status on Microalbuminuria in Type 2 Diabetic Patients

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

BACKGROUND: There are several controversies regarding the association between serum magnesium depletion and microalbuminuria in type 2 diabetic patients.

OBJECTIVE: Therefore, this study aimed to assess serum magnesium concentrations in Type 2 diabetic patients with microalbuminuria and normoalbuminuria in Birjand, Iran, in 2019.

METHODS: In this cross-sectional study, 25 type 2 diabetes patients with microalbuminuria were enrolled as the case group and 25 type 2 diabetes patients with normoalbuminuria as the control group. Both groups were matched for age, sex, hypertension, and dyslipidemia. Blood samples were obtained for serum magnesium measurement.

RESULTS: Our findings showed no significant difference between serum magnesium concentration in the case and control groups (mean serum magnesium concentration for case group: 2.34 ± 0.35 mg/dl and control group: 2.27 ± 0.33 mg/dl). Pearson correlation coefficient analysis did not show any correlation between serum magnesium levels and urine albumin levels in patients with microalbuminuria versus patients with normoalbuminuria (r = 0.06, p = 0.67).

CONCLUSION: This study did not indicate a correlation between serum magnesium concentrations and microalbuminuria in Type 2 diabetic patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

Cardiovascular & hematological agents in medicinal chemistry - 21(2023), 1 vom: 25., Seite 55-59

Sprache:

Englisch

Beteiligte Personen:

Rezaei, Maryam [VerfasserIn]
Khazaei, Reza [VerfasserIn]
Mohaqiq, Zabihullah [VerfasserIn]
Raeesi, Vajehallah [VerfasserIn]
Farkhondeh, Tahereh [VerfasserIn]
Samarghandian, Saeed [VerfasserIn]

Links:

Volltext

Themen:

Blood samples
Hypertension and dyslipidemia
I38ZP9992A
Journal Article
Magnesium
Microalbuminuria
Pearson correlation coefficient analysis
Serum magnesium concentration
Type 2 diabetes

Anmerkungen:

Date Completed 08.02.2023

Date Revised 08.02.2023

published: Print

Citation Status MEDLINE

doi:

10.2174/1871525720666220425120457

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM339986360